Insiders LianBio

Equities

LIANY

US53000N1081

Market Closed - OTC Markets Other stock markets 12:57:15 18/05/2024 am IST			5-day change	1st Jan Change
0.3256 ^USD	+7.73%		+1.75%	-92.72%

10/05	China's Zeekr prices US IPO at top of range to raise $441 million	RE
07/05	Geely's EV Unit Zeekr Targets Up to $367.5 Million From NYSE IPO	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LianBio Finance Chief Resigns, Names Interim CFO	20/12	MT
LianBio CEO Yizhe Wang Resigns; Board Member Adam Stone Named in Interim	20/12	MT
Lianbio Announces Resignation of Yizhe Wang as Member of the Board of Directors	20/12	CI
Lianbio Announces Chief Executive Officer Changes	20/12	CI
LianBio Announces the Resignation of Debra Yu, M.D. as President and Chief Strategy Officer, Effective January 1, 2023	14/22/14	CI
LianBio Announces Formation of Scientific Advisory Board	15/22/15	CI
LianBio Appoints Wei Wei Chen to Board of Directors	07/22/07	CI
LianBio Announces Infigratinib Approved Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China	21/21/21	AQ
LianBio Announces Approval of Infigratinib Under Special Named Patient Program for the Treatment of Cholangiocarcinoma in the Pilot Zone of Hainan Province in China	21/21/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW